NASDAQ:CNCE

Concert Pharmaceuticals SEC Filings & 10K Form

$4.19
+0.14 (+3.46 %)
(As of 06/21/2021 02:31 PM ET)
Add
Compare
Today's Range
$4.00
$4.19
50-Day Range
$3.77
$4.73
52-Week Range
$3.68
$13.50
Volume5,879 shs
Average Volume387,271 shs
Market Capitalization$134.81 million
P/E RatioN/A
Dividend YieldN/A
Beta0.5

Concert Pharmaceuticals (NASDAQ:CNCE) SEC Filings

DateFilerForm TypeView
06/11/2021
7:46 AM
Concert Pharmaceuticals (Issuer)
van Heek Christi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2021
7:43 AM
Concert Pharmaceuticals (Issuer)
JAEGER WILFRED E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2021
7:41 AM
Concert Pharmaceuticals (Issuer)
HUTT PETER BARTON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2021
7:40 AM
Concert Pharmaceuticals (Issuer)
Hoeiland Jesper (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2021
7:38 AM
Barrett Ronald W (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2021
7:37 AM
Auchincloss Thomas G (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2021
7:36 AM
ALDRICH RICHARD (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2021
7:00 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2021
7:01 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2021
6:12 AM
Concert Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2021
6:10 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2021
6:06 AM
Concert Pharmaceuticals (Filer)
Form DEFA14A
04/27/2021
6:05 AM
Concert Pharmaceuticals (Filer)
Form DEF 14A
02/25/2021
6:13 AM
Concert Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/25/2021
6:11 AM
Concert Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2021
6:07 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/17/2021
8:42 PM
Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
8:34 PM
Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
8:31 PM
Concert Pharmaceuticals (Issuer)
Munsie Jeffrey A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
8:27 PM
Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
8:21 PM
Becker Marc A. (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2021
3:39 PM
Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2021
3:38 PM
Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2021
3:36 PM
Concert Pharmaceuticals (Issuer)
Munsie Jeffrey A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2021
3:35 PM
Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2021
3:32 PM
Becker Marc A. (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
3:05 PM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2020
11:15 PM
Concert Pharmaceuticals (Filer)
Form EFFECT
11/05/2020
6:18 AM
Concert Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/05/2020
5:07 AM
Concert Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2020
5:04 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2020
6:58 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/01/2020
3:01 PM
Concert Pharmaceuticals (Issuer)
HUTT PETER BARTON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2020
4:44 PM
Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2020
4:43 PM
Becker Marc A. (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2020
6:21 AM
Concert Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2020
6:11 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2020
8:02 AM
Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
4:07 PM
Concert Pharmaceuticals (Issuer)
van Heek Christi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
4:06 PM
Concert Pharmaceuticals (Issuer)
JAEGER WILFRED E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
4:04 PM
Concert Pharmaceuticals (Issuer)
HUTT PETER BARTON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
4:03 PM
Concert Pharmaceuticals (Issuer)
Hoeiland Jesper (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
4:02 PM
Barrett Ronald W (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
4:01 PM
Auchincloss Thomas G (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2020
6:27 AM
Concert Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2020
6:23 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2020
6:32 AM
Concert Pharmaceuticals (Filer)
Form DEFA14A
04/28/2020
6:31 AM
Concert Pharmaceuticals (Filer)
Form DEF 14A
03/16/2020
6:23 AM
Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
6:29 AM
Concert Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2020
6:24 AM
Concert Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2020
6:19 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
2:13 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Concert Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2020
11:57 AM
BANK OF AMERICA CORP /DE/ (Filed by)
Concert Pharmaceuticals (Subject)
Form SC 13G
02/12/2020
9:43 AM
Concert Pharmaceuticals (Subject)
DIMENSIONAL FUND ADVISORS LP (Filed by)
Form SC 13G
02/10/2020
1:19 PM
BlackRock Inc. (Filed by)
Concert Pharmaceuticals (Subject)
Form SC 13G/A
02/06/2020
12:34 PM
Arkin Moshe (Filed by)
Concert Pharmaceuticals (Subject)
Form SC 13G
02/05/2020
10:26 AM
BlackRock Inc. (Filed by)
Concert Pharmaceuticals (Subject)
Form SC 13G/A
02/04/2020
10:30 AM
Auchincloss Thomas G (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2020
3:46 PM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2020
5:13 AM
Concert Pharmaceuticals (Filer)
Form 424B5
01/23/2020
1:21 PM
Concert Pharmaceuticals (Subject)
INGALLS & SNYDER LLC (Filed by)
Form SC 13G/A
01/22/2020
8:52 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2019
3:05 PM
Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2019
3:05 PM
Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2019
6:06 AM
Concert Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2019
6:03 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2019
5:45 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2019
7:58 AM
Concert Pharmaceuticals (Issuer)
van Heek Christi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2019
3:37 PM
Concert Pharmaceuticals (Issuer)
Munsie Jeffrey A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2019
3:34 PM
Concert Pharmaceuticals (Issuer)
Munsie Jeffrey A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/05/2019
3:01 PM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2019
5:20 AM
Concert Pharmaceuticals (Issuer)
Lynch Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
5:18 AM
Becker Marc A. (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
5:12 AM
Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2019
3:00 PM
Concert Pharmaceuticals (Issuer)
HUTT PETER BARTON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2019
6:38 AM
Concert Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2019
6:36 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2019
2:31 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Concert Pharmaceuticals (Subject)
Form SC 13G/A
06/17/2019
8:14 PM
ALDRICH RICHARD (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
8:07 PM
Concert Pharmaceuticals (Issuer)
JAEGER WILFRED E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
8:06 PM
Concert Pharmaceuticals (Issuer)
HUTT PETER BARTON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
8:05 PM
Barrett Ronald W (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
8:03 PM
Auchincloss Thomas G (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
8:02 PM
Concert Pharmaceuticals (Issuer)
van Heek Christi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
8:01 PM
Concert Pharmaceuticals (Issuer)
Hoeiland Jesper (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
3:37 PM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2019
3:16 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Concert Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
4:14 PM
Concert Pharmaceuticals (Issuer)
Hoeiland Jesper (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/02/2019
6:27 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2019
6:26 AM
Concert Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2019
6:23 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2019
6:22 AM
Concert Pharmaceuticals (Filer)
Form DEF 14A
04/24/2019
3:27 PM
Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2019
3:34 PM
Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
3:15 PM
Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
2:17 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Concert Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/02/2019
1:50 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Concert Pharmaceuticals (Subject)
Form SC 13G/A
03/01/2019
3:43 PM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2019
6:26 AM
Concert Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
This page was last updated on 6/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.